NervGen Pharma News and Activities

NervGen Pharma is a company listed under the stock ticker NGENF (CA).

View the org chart displaying its 13 main executives

Most searched biographies at NervGen Pharma

• Adam Rogers, Chief Executive Officer and Chairman of the Board
• Brian Bayley, Director
• John Ruffolo, Director

Popular executive movements at NervGen Pharma

• Keith Vendola has joined the company as Chief Financial Officer  (posted on April 28 2026).
• Shamim Ruff has joined the company as Chief Regulatory Affairs Officer  (posted on March 4 2026).
• Christine Mcsherry has joined the company as Senior Vice President, Patient Advocacy and Clinical Affairs  (posted on March 4 2026).

Click here to view some more movements at NervGen Pharma

Create your alert
to follow the executive moves at NervGen Pharma.

NervGen Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by NervGen Pharma

• GDPR Cookie Compliance – Cookie Banner, Cookie Consent, Cookie Notice – CCPA, DSGVO, RGPD
• News Releases Archives - NervGen Pharma

Social media about NervGen Pharma

• NervGen Pharma on Wikipedia, Google News & Yahoo Finance
• NervGen Pharma on LinkedIn, X (Twitter) & YouTube